# Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial

> **NCT07088328** · NA · NOT_YET_RECRUITING · sponsor: **Alexandria University** · enrollment: 30 (estimated)

## Conditions studied

- Hypoxic-Ischemic Encephalopathy
- Neonatal Encephalopathy
- Pentoxifylline Adverse Reaction

## Interventions

- **DRUG:** Pentoxifylline
- **OTHER:** placebo distilled water

## Key facts

- **NCT ID:** NCT07088328
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-03-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07088328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07088328, "Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07088328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*